Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
Saved in:
Main Authors: | Bin Jiang, Z Kevin Lu, Xiaomo Xiong |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/194c81f09dbd4beb92927c4c7200bc95 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms’ R&D Investment in China? An Event Study Approach
by: Yuanyuan Hu, et al.
Published: (2021) -
The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
by: Ying Yang, et al.
Published: (2021) -
Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
by: Minghuan Jiang, et al.
Published: (2013) -
Simulation of Optimum Offer Prices in the Contract System in State and Municipal Procurement
by: A. N. Kislyakov
Published: (2019) -
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
by: Nkeiruka Grace Osuafor, et al.
Published: (2021)